This research was funded by the National Nature Science Foundation Youth Project(Grant No.81702514);the National Natural Science Foundation of China(Grant No.81430058);the Clinical Research Project of Shanghai Municipal Commission of Health and Family Planning(Grant No.20184Y0130).
Fusion between the transmembrane protease serine 2 and v-ets erythroblastosis virus E26 oncogene homolog(TMPRSS2-ERG fusion)is a common genetic alteration in prostate cancer among Western populations and has been sugg...
Prostate cancer is a clinically heterogeneous disease, with some men having indolent disease that can safely be observed, while others have aggressive, lethal disease. Over the past decade, researchers have begun to u...
Speckle-type POZ (pox virus and zinc finger protein) protein (SPOP) is anE3 ubiquitin ligase adaptor protein that specifically promotes the ubiquitination and proteasome degradation of proteins. SPOP mutations are...
Prostate cancer is a clinically and molecularly heterogeneous disease. Understanding the biologic underpinning of prostate cancer is necessary to best determine how biology is associated with the risk of disease progr...
Since the recent identification of recurrent gene fusions in prostate cancer betweenmembers of the ETS family of genes and transmembrane protease, serine 2 (TM PRSS2), a tremendous amount of interest has developed i...